Suppr超能文献

增塑剂对血浆蛋白结合率测定的干扰

Interference of Plasticizers on Plasma Protein Binding Measurements.

作者信息

Harrison Makayla, Jordan Samantha, Di Li

机构信息

Pfizer Worldwide Research and Development, Groton, CT, USA.

AstraZeneca, New Haven, CT, USA.

出版信息

AAPS J. 2024 Dec 10;27(1):10. doi: 10.1208/s12248-024-00988-6.

Abstract

Accurate measurement of plasma protein binding (PPB) is of critical importance in drug discovery. Methodologies for PPB measurement continue to evolve to address the challenges of highly bound compounds. In order to generate high quality PPB data, it is crucial to not only apply state-of-the-art methods and highly sensitive and selective detectors, but also use high-quality plasma. In this study, we found that plasticizers, leaching from polyvinyl chloride (PVC) plasma storage bags, interfered with drug binding to both human α1-acid glycoprotein (AAG) and human serum albumin (HSA). Several AAG and HSA binding drugs were used to probe the differences in PPB using blood/plasma collected and stored in PVC bags or glass tubes through vacutainers. The results showed that plasma collected using vacutainers into the glass tubes has lower plasma fraction unbound (f) values than those from the PVC bags. The f differences can be as high as 32-fold. Hence, it is recommended to use vacutainers and glass tubes rather than PVC bags, for blood collection and plasma storage. Plasma from animal species collected using polypropylene syringes into polyethylene tubes showed no differences in f from plasma collected using vacutainers into glass tubes. Not all compounds are sensitive to plasticizer interference for PPB. It is therefore important to select appropriate positive controls for f measurement, such as warfarin for HSA and imatinib for AAG, to monitor the quality of plasma and minimize the interference from plasticizers.

摘要

准确测量血浆蛋白结合率(PPB)在药物研发中至关重要。PPB测量方法不断发展以应对高结合化合物带来的挑战。为了生成高质量的PPB数据,不仅要应用最先进的方法和高灵敏度及选择性的检测器,使用高质量的血浆也很关键。在本研究中,我们发现从聚氯乙烯(PVC)血浆储存袋中浸出的增塑剂会干扰药物与人α1-酸性糖蛋白(AAG)和人血清白蛋白(HSA)的结合。使用几种与AAG和HSA结合的药物,通过真空采血管收集并储存在PVC袋或玻璃管中的血液/血浆来探究PPB的差异。结果表明,使用真空采血管收集到玻璃管中的血浆,其血浆未结合分数(f)值低于从PVC袋中收集的血浆。f值差异可高达32倍。因此,建议使用真空采血管和玻璃管而非PVC袋来进行血液采集和血浆储存。使用聚丙烯注射器收集到聚乙烯管中的动物血浆,其f值与使用真空采血管收集到玻璃管中的血浆无差异。并非所有化合物对PPB的增塑剂干扰都敏感。因此,为f测量选择合适的阳性对照很重要,例如用于HSA的华法林和用于AAG的伊马替尼,以监测血浆质量并最小化增塑剂的干扰。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验